RxDoctor Payments DataLook up a doctor →

Charles Hall, MD

Child & Adolescent Psychiatry · Richmond, VANPI 1598973471

Payments from drug & device makers

$10,275in general payments, 2019–2025

Across 567 payments — averaging $18.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Supernus Pharmaceuticals, Inc.$1K
  • Otsuka America Pharmaceutical, Inc.$903
  • Neurocrine Biosciences, Inc.$761
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$716
  • Johnson & Johnson$563
  • Ironshore Pharmaceuticals Inc.$558
  • plus $6K from 28 others

What the payments were for

  • Food & beverage$9,83096%
  • Education$4454%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,275 in reported general payments places this provider in the 95th percentile of 115 child & adolescent psychiatry providers in Virginia.

See all child & adolescent psychiatry providers in Virginia

Medicare billing

Part B allowed, 2024
$7,143
Medicare patients
13
Services billed
72

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Aripiprazole40$7,645
Aripiprazole OdtAripiprazole12$7,401
Duloxetine Hcl69$5,866
Atomoxetine Hcl38$4,375
Olanzapine OdtOlanzapine17$2,322
Methylphenidate Hcl CdMethylphenidate Hcl24$2,165
Clozapine13$1,792
Quetiapine Fumarate65$1,226
Quetiapine Fumarate ErQuetiapine Fumarate14$1,068
Methylphenidate ErMethylphenidate Hcl11$946
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine55$868
Divalproex Sodium20$848
Lamotrigine25$841
Trazodone Hcl45$722
Oxcarbazepine26$717

Paid to pharmacies, not to this prescriber.

Other child & adolescent psychiatry in Richmond

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →